Multiple Sclerosis Sitemap

  • Multiple Sclerosis
  • The Facts About Multiple Sclerosis
  • Acquired Pendular Nystagmus And Multiple Sclerosis
  • Alternative Help For Multiple Sclerosis
  • Care For Multiple Sclerosis
  • Early Symptoms Of Multiple Sclerosis
  • Glyconutrients And Multiple Sclerosis
  • Historical Significance Of Multiple Sclerosis
  • Tips For Living With Multiple Sclerosis
  • Understanding Multiple Sclerosis
  • Multiple Sclerosis Diet
  • Living With Multiple Sclerosis Pain
  • What Multiple Sclerosis Patients Need To Know
  • Multiple Sclerosis Questions
  • Advances In Multiple Sclerosis Research
  • Multiple Sclerosis Signs Symptoms
  • Multiple Sclerosis Symptoms
  • The Facts About Multiple Sclerosis Treatment
  • Multiple Sclerosis Treatment
  • Multiple Sclerosis Support Group
  • Options
  • Translated Pages
  • Multiple Sclerosis News Archives






  • Just enter your name and email to receive your FREE Multiple Sclerosis gift.




    Name:                   
    Email Address:

    Your name and email address will not be sold, shared or disclosed to anyone. We promise to respect your privacy.



    Multiple Sclerosis News:
    Thousands expected for bike ride for multiple sclerosis research - Columbia Missourian

    Thousands expected for bike ride for multiple sclerosis research
    Columbia Missourian, MO - 18 hours ago
    This is the 24th year the Gateway Area Chapter of the National Multiple Sclerosis Society will present the Express Scripts Gateway Ride. .
    ..


    'Bed-bound' by home care prices
    A multiple sclerosis sufferer says he has been left bed-bound by the tripling of home care costs imposed by a council EUR¦..


    Team cycles to end Multiple Sclerosis - The Times of Trenton - NJ.com

    Team cycles to end Multiple Sclerosis
    The Times of Trenton - NJ.com, NJ - Sep 3, 2008
    Robbinsville residents Chris Sharp, Scott Klein, Eric Toppy and David Pethybridge will team up on Sunday to end multiple sclerosis (MS). .
    ..


    Multiple Sclerosis Badges of Honor
    My body has a disease called multiple sclerosis. That means many scars. The outside of my body has a scar on my head that is 41 years old. My abdomen has two long scars making a cross, hip bone to hip bone from a surgery in 1990 and ...


    Biogen Idec testing Tysabri as a cancer treatment - Boston Globe

    Biogen Idec testing Tysabri as a cancer treatment
    Boston Globe, United States - 5 hours ago
    Tysabri is already approved for treating multiple sclerosis and Crohn's disease, but there have been setbacks. Tysabri was originally launched in 2004 but .
    Biogens battered MS drug in cancer treatment trials Mass High Tech
    all 2 news articles
    ..


    Opexa Therapeutics And Myelin Repair Foundation Partner On Novel Multiple Sclerosis Research Program (Medical News Today)
    Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, announced the establishment of a novel MS research partnership with the Myelin Repair Foundation, Inc. (MRF)...


    Shape - Give back while you get fit: support a charity this fall by walking, biking, or running in one of these events
    September 1, 2008 -- NATIONWIDE HERSHEY'S TOUR DE PINK (October 6; hersheys.com/Pledge) support the Young Survival Coalition on this virtual bike ride (you accumulate...


    BioMS wins FDA fast track designation for multiple sclerosis drug - Pharmaceutical Business Review

    BioMS wins FDA fast track designation for multiple sclerosis drug
    Pharmaceutical Business Review - 5 hours ago
    . "Our receipt of fast track designation for dirucotide in the US is a significant milestone for both BioMS Medical and the multiple sclerosis community. .
    ..


    Chelation and Multiple Sclerosis
    Multiple Sclerosis (MS) is an autoimmune disease in which the central nervous system is affected. The body attacks the myelin sheath covering your nerves, resulting in injury and inflammation in the sheath and eventually the nerves ...


    Multiple Sclerosis genetics consortium moves forward
    In 2007, the International MS Genetics Consortium, which the National MS Society helped to create, published the results of a trailblazing study in which they analyzed 3000 genetic samples - from 1000 people with MS and their parents ...


    Opexa and MRF collaborate on multiple sclerosis research program - Trading Markets (press release)

    Opexa and MRF collaborate on multiple sclerosis research program
    Trading Markets (press release), CA - 20 hours ago
    As part of this collaboration, Opexa and the Myelin Repair Foundation (MRF) will work to identify therapeutically relevant biomarkers in multiple sclerosis .
    ..


    HealthDay - Clinical Trials Update: Aug. 14, 2008
    August 14, 2008 -- Multiple Sclerosis Pancreatic Cancer Urticaria Here are the latest clinical trials, courtesy of CenterWatch : Multiple Sclerosis If you are...


    Deseret News (Salt Lake City) - Society to honor Utahns at gala
    August 17, 2008 -- The Utah chapter of the National Multiple Sclerosis Society will honor two major contributors to scientific research and medical care worldwide along...


    Business Wire - Three Utah Non-Profit Organizations Chosen as Finalists for Humana's Utah Benefits Program
    August 20, 2008 -- Winner will receive $100,000 grant for area program SALT LAKE CITY -- Three Utah charitable organizations have been selected as finalists for...


    Opexa Therapeutics And Myelin Repair Foundation Partner On Novel .
    (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, announced the establishment of a novel MS research ...


    Opexa Therapeutics and Myelin Repair Foundation Partner on Novel Multiple Sclerosis Research Program (Centre Daily Times)
    Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, today announced the establishment of a novel MS research partnership with the Myelin Repair Foundation, Inc. (MRF). As part of this collaboration, Opexa and the MRF will work to identify ...


    Thousands expected for bike ride for multiple sclerosis research (Columbia Missourian)
    COLUMBIA EUR” Three thousand bicycle riders will take off from the Midway Expo Center, located on Interstate 70 at Exit 121, this weekend to raise money and awareness for multiple sclerosis, a disease affecting about 400,000 people nationwide. This is the 24th year the Gateway Area Chapter of the National Multiple Sclerosis Society will present the Express Scripts Gateway Ride. It is part of the ...


    Opexa Therapeutics and Myelin Repair Foundation Partner on Novel Multiple Sclerosis Research Program (Business Wire via Yahoo! Finance)
    THE WOODLANDS, Texas----Opexa Therapeutics, Inc. , a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis and diabetes, today announced the establishment of a novel MS research partnership with the Myelin Repair Foundation, Inc. ...


    Yoga and Multiple Sclerosis: A journey to health and healing
    Yoga for people with multiple sclerosis? Absolutely! Studies show that after six months of practicing yoga, fatigue and other symptoms are significantly reduced. Yoga and Multiple Sclerosis: A Journey to Health and Healing is a ...


    Study confirms increased MS rates
    A new study appears to confirm long-held suspicions that local communities Morrison and Paw Paw have higher-than-average rates of multiple sclerosis - particularly among women EUR¦..


    Pembongkar Suap Itu Berjuang Melawan Penyakit Langka
    EUR¦ sclerosis, pita suara dan kakinya memang semakin lemah. Namun dia tetap tak mengenal kata menyerah. Liputan6.com, Jakarta: Suara Meilono Soewondo tak lagi lantang, serak parau kini EUR¦..


    BioMS multiple sclerosis drug gets FDA fast track - Reuters

    BioMS multiple sclerosis drug gets FDA fast track
    Reuters - Sep 4, 2008
    TO: Quote, Profile, Research, Stock Buzz) said on Thursday its lead drug for the treatment of multiple sclerosis was granted fast-track designation from the .
    BioMS Medical says its dirucotide for treatment of multiple . RTT News
    BioMS says its lead drug has received a fast-track designation . The Canadian Press
    Edmonton MS drug-trial gets fast-tracked in US Canada.com
    Network MĂdica
    all 39 news articles
    ..


    Opexa Therapeutics and Myelin Repair Foundation Partner on Novel . - MarketWatch

    Opexa Therapeutics and Myelin Repair Foundation Partner on Novel .
    MarketWatch - Sep 3, 2008
    a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and .
    Opexa research partnership to focus on MS biomarkers Bizjournals.com
    all 18 news articles
    ..


    Business Wire - Acorda Therapeutics' Preclinical Pipeline Named One of the 10 Most Promising Neuroscience Projects Available for Partnering by Windhover
    August 21, 2008 -- HAWTHORNE, N.Y. -- Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the Company's preclinical pipeline has been selected by Windhover...


    Regulatory Immune Cells Not Defective In Multiple Sclerosis (Medical News Today)
    Multiple sclerosis (MS) is a chronic inflammatory disease that causes neurodegeneration, resulting in numerous physical and mental disabilities. It is thought to be caused by out of control immune cells that attack the proteins that make up the protective sheath in which nerve cells are encased...


    Regulatory immune cells may not be defective in Multiple Sclerosis
    Multiple sclerosis (MS) is a chronic inflammatory disease that causes neurodegeneration, resulting in numerous physical and mental disabilities. It is thought to be caused by out of control immune cells that attack the proteins that ...


    BYU Chemists Fight Cancer
    BYU chemists have made a significant discovery in the battle against cancer, and possibly multiple sclerosis, by developing an improved way for synthesizing cladribine, a cancer-fighting drug EUR¦..


    The 2008 RONA MS Bike Tour Raises $1250000 for Multiple Sclerosis! - Market Wire (press release)

    The 2008 RONA MS Bike Tour Raises $1250000 for Multiple Sclerosis!
    Market Wire (press release) - Sep 3, 2008
    The Multiple Sclerosis Society of Canada, Quebec Division is happy to announce that the nineteenth edition of the RONA MS Bike Tour was a resounding success .
    ..

    BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track . (CNW Group via Yahoo! Finance)
    BioMS Medical Corp. , a leading developer in the treatment of multiple sclerosis , today announced that the Food and Drug Administration of the United States has granted fast track designation for the Company's lead drug, dirucotide , for the treatment of secondary progressive MS ...


    BioMS multiple sclerosis drug gets FDA fast track (The Globe and Mail)
    OTTAWA (Reuters) - Canadian biotechnology company BioMS Medical Corp said on Thursday its lead drug for the treatment of multiple sclerosis was granted fast-track designation from the U.S. Food and Drug Administration...



    Today's Tip On Multiple Sclerosis

    It's extremely important that multiple sclerosis patients work with their doctor, family and support groups to maintain their quality of life. Having MS does not mean that you have to give up your privacy or independence. Once you have been diagnosed, immediately make modifications to your lifestyle that will make this disease more manageable. By doing this, you'll protect your safety and give your family some peace of mind. More multiple sclerosis information can be found by contacting the Multiple Sclerosis Foundation.